↓ Skip to main content

Cochrane Database of Systematic Reviews

Molindone for schizophrenia and severe mental illness

Overview of attention for article published in Cochrane database of systematic reviews, January 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs
1 blog
twitter
3 X users
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
147 Mendeley
Title
Molindone for schizophrenia and severe mental illness
Published in
Cochrane database of systematic reviews, January 2007
DOI 10.1002/14651858.cd002083.pub2
Pubmed ID
Authors

Anne‐Marie Bagnall, Mark Fenton, Jos Kleijnen, Ruth Lewis

Abstract

Antipsychotic therapy is the mainstay of treatment for people with schizophrenia. In recent years new or atypical antipsychotics have been introduced. These are less likely to produce movement disorders and raise serum prolactin. Researchers have suggested that molindone should be classified as an atypical antipsychotic.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
South Africa 1 <1%
Unknown 145 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 14%
Researcher 17 12%
Student > Ph. D. Student 17 12%
Student > Bachelor 17 12%
Student > Doctoral Student 10 7%
Other 30 20%
Unknown 35 24%
Readers by discipline Count As %
Medicine and Dentistry 44 30%
Psychology 19 13%
Nursing and Health Professions 15 10%
Social Sciences 6 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Other 19 13%
Unknown 39 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2023.
All research outputs
#3,113,420
of 25,383,344 outputs
Outputs from Cochrane database of systematic reviews
#5,857
of 12,571 outputs
Outputs of similar age
#11,764
of 172,356 outputs
Outputs of similar age from Cochrane database of systematic reviews
#16
of 68 outputs
Altmetric has tracked 25,383,344 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,571 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 37.0. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,356 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.